APO Research
Talk to an analyst

APO RESEARCH · REPORT

Romosozumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Romosozumab Market Analysis and Forecast 2026-2032

23 December 2025191 pages

Choose your research edition.

Industry ResearchRomosozumab Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Romosozumab Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Romosozumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Romosozumab Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Romosozumab Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Romosozumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Romosozumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Romosozumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Romosozumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Romosozumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Romosozumab include Thermo Fisher Scientific, Bristol-Myers Squibb and Celgene, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Romosozumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Romosozumab, also provides the sales of main regions and countries. Of the upcoming market potential for Romosozumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Romosozumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Romosozumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Romosozumab sales, projected growth trends, production technology, application and end-user industry.

Romosozumab Segment by Company

Thermo Fisher Scientific

Bristol-Myers Squibb

Celgene

Romosozumab Segment by Type

25 mg/vial

75 mg/vial

Romosozumab Segment by Application

Beta-thalassemia

MDS-RS

Romosozumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Romosozumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Romosozumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Romosozumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Romosozumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Romosozumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Romosozumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Romosozumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 25 mg/vial Major Manufacturers Table 3. 75 mg/vial Major Manufacturers Table 4. Global Romosozumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Beta-thalassemia Major Manufacturers Table 6. MDS-RS Major Manufacturers Table 7. Romosozumab Industry Trends Table 8. Romosozumab Industry Drivers Table 9. Romosozumab Industry Opportunities and Challenges Table 10. Romosozumab Industry Restraints Table 11. Global Romosozumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Romosozumab Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Romosozumab Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Romosozumab Revenue Market Share by Region (2021-2026) Table 15. Global Romosozumab Revenue Market Share by Region (2027-2032) Table 16. Global Romosozumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Romosozumab Sales by Region (2021-2026) & (k units) Table 18. Global Romosozumab Sales by Region (2027-2032) & (k units) Table 19. Global Romosozumab Sales Market Share by Region (2021-2026) Table 20. Global Romosozumab Sales Market Share by Region (2027-2032) Table 21. Global Romosozumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Romosozumab Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Romosozumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Romosozumab Sales Market Share by Manufacturers (2021-2026) Table 25. Global Romosozumab Sales Price (USD/unit) of Manufacturers (2021-2026) Table 26. Global Romosozumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Romosozumab Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Romosozumab Manufacturers, Product Type & Application Table 29. Global Romosozumab Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Romosozumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Romosozumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Romosozumab Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Romosozumab Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Romosozumab Revenue Market Share by Type (2021-2026) Table 36. Global Romosozumab Revenue Market Share by Type (2027-2032) Table 37. Global Romosozumab Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Romosozumab Sales by Type (2021-2026) & (k units) Table 39. Global Romosozumab Sales by Type (2027-2032) & (k units) Table 40. Global Romosozumab Sales Market Share by Type (2021-2026) Table 41. Global Romosozumab Sales Market Share by Type (2027-2032) Table 42. Global Romosozumab Price by Type (2021-2026) & (USD/unit) Table 43. Global Romosozumab Price by Type (2027-2032) & (USD/unit) Table 44. Global Romosozumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Romosozumab Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Romosozumab Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Romosozumab Revenue Market Share by Application (2021-2026) Table 48. Global Romosozumab Revenue Market Share by Application (2027-2032) Table 49. Global Romosozumab Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Romosozumab Sales by Application (2021-2026) & (k units) Table 51. Global Romosozumab Sales by Application (2027-2032) & (k units) Table 52. Global Romosozumab Sales Market Share by Application (2021-2026) Table 53. Global Romosozumab Sales Market Share by Application (2027-2032) Table 54. Global Romosozumab Price by Application (2021-2026) & (USD/unit) Table 55. Global Romosozumab Price by Application (2027-2032) & (USD/unit) Table 56. Thermo Fisher Scientific Company Information Table 57. Thermo Fisher Scientific Business Overview Table 58. Thermo Fisher Scientific Romosozumab Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 59. Thermo Fisher Scientific Romosozumab Product Portfolio Table 60. Thermo Fisher Scientific Recent Development Table 61. Bristol-Myers Squibb Company Information Table 62. Bristol-Myers Squibb Business Overview Table 63. Bristol-Myers Squibb Romosozumab Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 64. Bristol-Myers Squibb Romosozumab Product Portfolio Table 65. Bristol-Myers Squibb Recent Development Table 66. Celgene Company Information Table 67. Celgene Business Overview Table 68. Celgene Romosozumab Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Celgene Romosozumab Product Portfolio Table 70. Celgene Recent Development Table 71. North America Romosozumab Revenue by Type (2021-2026) & (US$ Million) Table 72. North America Romosozumab Revenue by Type (2027-2032) & (US$ Million) Table 73. North America Romosozumab Sales by Type (2021-2026) & (k units) Table 74. North America Romosozumab Sales by Type (2027-2032) & (k units) Table 75. North America Romosozumab Sales Price by Type (2021-2026) & (USD/unit) Table 76. North America Romosozumab Sales Price by Type (2027-2032) & (USD/unit) Table 77. North America Romosozumab Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Romosozumab Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Romosozumab Sales by Application (2021-2026) & (k units) Table 80. North America Romosozumab Sales by Application (2027-2032) & (k units) Table 81. North America Romosozumab Sales Price by Application (2021-2026) & (USD/unit) Table 82. North America Romosozumab Sales Price by Application (2027-2032) & (USD/unit) Table 83. North America Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America Romosozumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 85. North America Romosozumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 86. North America Romosozumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 87. North America Romosozumab Sales by Country (2021-2026) & (k units) Table 88. North America Romosozumab Sales by Country (2027-2032) & (k units) Table 89. North America Romosozumab Sales Price by Country (2021-2026) & (USD/unit) Table 90. North America Romosozumab Sales Price by Country (2027-2032) & (USD/unit) Table 91. United States Romosozumab Revenue (2021-2032) & (US$ Million) Table 92. Canada Romosozumab Revenue (2021-2032) & (US$ Million) Table 93. Mexico Romosozumab Revenue (2021-2032) & (US$ Million) Table 94. Europe Romosozumab Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Romosozumab Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Romosozumab Sales by Type (2021-2026) & (k units) Table 97. Europe Romosozumab Sales by Type (2027-2032) & (k units) Table 98. Europe Romosozumab Sales Price by Type (2021-2026) & (USD/unit) Table 99. Europe Romosozumab Sales Price by Type (2027-2032) & (USD/unit) Table 100. Europe Romosozumab Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Romosozumab Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Romosozumab Sales by Application (2021-2026) & (k units) Table 103. Europe Romosozumab Sales by Application (2027-2032) & (k units) Table 104. Europe Romosozumab Sales Price by Application (2021-2026) & (USD/unit) Table 105. Europe Romosozumab Sales Price by Application (2027-2032) & (USD/unit) Table 106. Europe Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Romosozumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Romosozumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Romosozumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 110. Europe Romosozumab Sales by Country (2021-2026) & (k units) Table 111. Europe Romosozumab Sales by Country (2027-2032) & (k units) Table 112. Europe Romosozumab Sales Price by Country (2021-2026) & (USD/unit) Table 113. Europe Romosozumab Sales Price by Country (2027-2032) & (USD/unit) Table 114. Germany Romosozumab Revenue (2021-2032) & (US$ Million) Table 115. France Romosozumab Revenue (2021-2032) & (US$ Million) Table 116. U.K. Romosozumab Revenue (2021-2032) & (US$ Million) Table 117. Italy Romosozumab Revenue (2021-2032) & (US$ Million) Table 118. Russia Romosozumab Revenue (2021-2032) & (US$ Million) Table 119. Spain Romosozumab Revenue (2021-2032) & (US$ Million) Table 120. Netherlands Romosozumab Revenue (2021-2032) & (US$ Million) Table 121. Switzerland Romosozumab Revenue (2021-2032) & (US$ Million) Table 122. Sweden Romosozumab Revenue (2021-2032) & (US$ Million) Table 123. Poland Romosozumab Revenue (2021-2032) & (US$ Million) Table 124. China Romosozumab Revenue by Type (2021-2026) & (US$ Million) Table 125. China Romosozumab Revenue by Type (2027-2032) & (US$ Million) Table 126. China Romosozumab Sales by Type (2021-2026) & (k units) Table 127. China Romosozumab Sales by Type (2027-2032) & (k units) Table 128. China Romosozumab Sales Price by Type (2021-2026) & (USD/unit) Table 129. China Romosozumab Sales Price by Type (2027-2032) & (USD/unit) Table 130. China Romosozumab Revenue by Application (2021-2026) & (US$ Million) Table 131. China Romosozumab Revenue by Application (2027-2032) & (US$ Million) Table 132. China Romosozumab Sales by Application (2021-2026) & (k units) Table 133. China Romosozumab Sales by Application (2027-2032) & (k units) Table 134. China Romosozumab Sales Price by Application (2021-2026) & (USD/unit) Table 135. China Romosozumab Sales Price by Application (2027-2032) & (USD/unit) Table 136. Asia Romosozumab Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Romosozumab Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Romosozumab Sales by Type (2021-2026) & (k units) Table 139. Asia Romosozumab Sales by Type (2027-2032) & (k units) Table 140. Asia Romosozumab Sales Price by Type (2021-2026) & (USD/unit) Table 141. Asia Romosozumab Sales Price by Type (2027-2032) & (USD/unit) Table 142. Asia Romosozumab Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Romosozumab Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Romosozumab Sales by Application (2021-2026) & (k units) Table 145. Asia Romosozumab Sales by Application (2027-2032) & (k units) Table 146. Asia Romosozumab Sales Price by Application (2021-2026) & (USD/unit) Table 147. Asia Romosozumab Sales Price by Application (2027-2032) & (USD/unit) Table 148. Asia Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Romosozumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Romosozumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Romosozumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 152. Asia Romosozumab Sales by Country (2021-2026) & (k units) Table 153. Asia Romosozumab Sales by Country (2027-2032) & (k units) Table 154. Asia Romosozumab Sales Price by Country (2021-2026) & (USD/unit) Table 155. Asia Romosozumab Sales Price by Country (2027-2032) & (USD/unit) Table 156. Japan Romosozumab Revenue (2021-2032) & (US$ Million) Table 157. South Korea Romosozumab Revenue (2021-2032) & (US$ Million) Table 158. India Romosozumab Revenue (2021-2032) & (US$ Million) Table 159. Australia Romosozumab Revenue (2021-2032) & (US$ Million) Table 160. Taiwan Romosozumab Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Romosozumab Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Romosozumab Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Romosozumab Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Romosozumab Sales by Type (2021-2026) & (k units) Table 165. SAMEA Romosozumab Sales by Type (2027-2032) & (k units) Table 166. SAMEA Romosozumab Sales Price by Type (2021-2026) & (USD/unit) Table 167. SAMEA Romosozumab Sales Price by Type (2027-2032) & (USD/unit) Table 168. SAMEA Romosozumab Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Romosozumab Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Romosozumab Sales by Application (2021-2026) & (k units) Table 171. SAMEA Romosozumab Sales by Application (2027-2032) & (k units) Table 172. SAMEA Romosozumab Sales Price by Application (2021-2026) & (USD/unit) Table 173. SAMEA Romosozumab Sales Price by Application (2027-2032) & (USD/unit) Table 174. SAMEA Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Romosozumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Romosozumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Romosozumab Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 178. SAMEA Romosozumab Sales by Country (2021-2026) & (k units) Table 179. SAMEA Romosozumab Sales by Country (2027-2032) & (k units) Table 180. SAMEA Romosozumab Sales Price by Country (2021-2026) & (USD/unit) Table 181. SAMEA Romosozumab Sales Price by Country (2027-2032) & (USD/unit) Table 182. Brazil Romosozumab Revenue (2021-2032) & (US$ Million) Table 183. Argentina Romosozumab Revenue (2021-2032) & (US$ Million) Table 184. Chile Romosozumab Revenue (2021-2032) & (US$ Million) Table 185. Colombia Romosozumab Revenue (2021-2032) & (US$ Million) Table 186. Peru Romosozumab Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Romosozumab Revenue (2021-2032) & (US$ Million) Table 188. Israel Romosozumab Revenue (2021-2032) & (US$ Million) Table 189. UAE Romosozumab Revenue (2021-2032) & (US$ Million) Table 190. Turkey Romosozumab Revenue (2021-2032) & (US$ Million) Table 191. Iran Romosozumab Revenue (2021-2032) & (US$ Million) Table 192. Egypt Romosozumab Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Romosozumab Distributors List Table 196. Romosozumab Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Romosozumab Image Figure 2. Global Romosozumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Romosozumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. 25 mg/vial Image Figure 5. 75 mg/vial Image Figure 6. Global Romosozumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Romosozumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Beta-thalassemia Image Figure 9. MDS-RS Image Figure 10. Global Romosozumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Romosozumab Revenue (2021-2032) & (US$ Million) Figure 12. Global Romosozumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Romosozumab Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Romosozumab Revenue Market Share by Region (2021-2032) Figure 15. Global Romosozumab Sales (2021-2032) & (k units) Figure 16. Global Romosozumab Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Romosozumab Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Romosozumab Sales YoY (2021-2032) & (k units) Figure 19. Europe Romosozumab Sales YoY (2021-2032) & (k units) Figure 20. China Romosozumab Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Romosozumab Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Romosozumab Sales YoY (2021-2032) & (k units) Figure 23. Global Romosozumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Romosozumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Romosozumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Romosozumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Romosozumab Revenue Market Share by Type (2021-2032) Figure 29. Global Romosozumab Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Romosozumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Romosozumab Sales Market Share by Type (2021-2032) Figure 32. Global Romosozumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Romosozumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Romosozumab Revenue Market Share by Application (2021-2032) Figure 35. Global Romosozumab Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Romosozumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Romosozumab Sales Market Share by Application (2021-2032) Figure 38. North America Romosozumab Revenue Share by Type (2021-2032) Figure 39. North America Romosozumab Sales Share by Type (2021-2032) Figure 40. North America Romosozumab Revenue Share by Application (2021-2032) Figure 41. North America Romosozumab Sales Share by Application (2021-2032) Figure 42. North America Romosozumab Revenue Share by Country (2021-2032) Figure 43. North America Romosozumab Sales Share by Country (2021-2032) Figure 44. Europe Romosozumab Revenue Share by Type (2021-2032) Figure 45. Europe Romosozumab Sales Share by Type (2021-2032) Figure 46. Europe Romosozumab Revenue Share by Application (2021-2032) Figure 47. Europe Romosozumab Sales Share by Application (2021-2032) Figure 48. Europe Romosozumab Revenue Share by Country (2021-2032) Figure 49. Europe Romosozumab Sales Share by Country (2021-2032) Figure 50. China Romosozumab Revenue Share by Type (2021-2032) Figure 51. China Romosozumab Sales Share by Type (2021-2032) Figure 52. China Romosozumab Revenue Share by Application (2021-2032) Figure 53. China Romosozumab Sales Share by Application (2021-2032) Figure 54. Asia Romosozumab Revenue Share by Type (2021-2032) Figure 55. Asia Romosozumab Sales Share by Type (2021-2032) Figure 56. Asia Romosozumab Revenue Share by Application (2021-2032) Figure 57. Asia Romosozumab Sales Share by Application (2021-2032) Figure 58. Asia Romosozumab Revenue Share by Country (2021-2032) Figure 59. Asia Romosozumab Sales Share by Country (2021-2032) Figure 60. SAMEA Romosozumab Revenue Share by Type (2021-2032) Figure 61. SAMEA Romosozumab Sales Share by Type (2021-2032) Figure 62. SAMEA Romosozumab Revenue Share by Application (2021-2032) Figure 63. SAMEA Romosozumab Sales Share by Application (2021-2032) Figure 64. SAMEA Romosozumab Revenue Share by Country (2021-2032) Figure 65. SAMEA Romosozumab Sales Share by Country (2021-2032) Figure 66. Romosozumab Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Romosozumab Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 25 mg/vial
  • 75 mg/vial
Applications
  • Beta-thalassemia
  • MDS-RS
Companies covered
  • Thermo Fisher Scientific
  • Bristol-Myers Squibb
  • Celgene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Romosozumab Market by Type
  3. 1.2.1 Global Romosozumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 25 mg/vial
  5. 1.2.3 75 mg/vial
  6. 1.3 Romosozumab Market by Application
  7. 1.3.1 Global Romosozumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Beta-thalassemia
  9. 1.3.3 MDS-RS
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Romosozumab Market Dynamics
  1. 2.1 Romosozumab Industry Trends
  2. 2.2 Romosozumab Industry Drivers
  3. 2.3 Romosozumab Industry Opportunities and Challenges
  4. 2.4 Romosozumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Romosozumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Romosozumab Revenue by Region
  3. 3.2.1 Global Romosozumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Romosozumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Romosozumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Romosozumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Romosozumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Romosozumab Sales by Region
  9. 3.4.1 Global Romosozumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Romosozumab Sales by Region (2021-2026)
  11. 3.4.3 Global Romosozumab Sales by Region (2027-2032)
  12. 3.4.4 Global Romosozumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Romosozumab Revenue by Manufacturers
  2. 4.1.1 Global Romosozumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Romosozumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Romosozumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Romosozumab Sales by Manufacturers
  6. 4.2.1 Global Romosozumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Romosozumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Romosozumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Romosozumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Romosozumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Romosozumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Romosozumab Manufacturers, Product Type & Application
  13. 4.7 Global Romosozumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Romosozumab Market CR5 and HHI
  16. 4.8.2 2025 Romosozumab Tier 1, Tier 2, and Tier 3
5 Romosozumab Market by Type
  1. 5.1 Global Romosozumab Revenue by Type
  2. 5.1.1 Global Romosozumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Romosozumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Romosozumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Romosozumab Sales by Type
  6. 5.2.1 Global Romosozumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Romosozumab Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Romosozumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Romosozumab Price by Type
6 Romosozumab Market by Application
  1. 6.1 Global Romosozumab Revenue by Application
  2. 6.1.1 Global Romosozumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Romosozumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Romosozumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Romosozumab Sales by Application
  6. 6.2.1 Global Romosozumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Romosozumab Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Romosozumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Romosozumab Price by Application
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Romosozumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Romosozumab Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Bristol-Myers Squibb
  8. 7.2.1 Bristol-Myers Squibb Company Information
  9. 7.2.2 Bristol-Myers Squibb Business Overview
  10. 7.2.3 Bristol-Myers Squibb Romosozumab Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bristol-Myers Squibb Romosozumab Product Portfolio
  12. 7.2.5 Bristol-Myers Squibb Recent Developments
  13. 7.3 Celgene
  14. 7.3.1 Celgene Company Information
  15. 7.3.2 Celgene Business Overview
  16. 7.3.3 Celgene Romosozumab Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Celgene Romosozumab Product Portfolio
  18. 7.3.5 Celgene Recent Developments
8 North America
  1. 8.1 North America Romosozumab Market Size by Type
  2. 8.1.1 North America Romosozumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Romosozumab Sales by Type (2021-2032)
  4. 8.1.3 North America Romosozumab Price by Type (2021-2032)
  5. 8.2 North America Romosozumab Market Size by Application
  6. 8.2.1 North America Romosozumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Romosozumab Sales by Application (2021-2032)
  8. 8.2.3 North America Romosozumab Price by Application (2021-2032)
  9. 8.3 North America Romosozumab Market Size by Country
  10. 8.3.1 North America Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Romosozumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Romosozumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Romosozumab Market Size by Type
  2. 9.1.1 Europe Romosozumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Romosozumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Romosozumab Price by Type (2021-2032)
  5. 9.2 Europe Romosozumab Market Size by Application
  6. 9.2.1 Europe Romosozumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Romosozumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Romosozumab Price by Application (2021-2032)
  9. 9.3 Europe Romosozumab Market Size by Country
  10. 9.3.1 Europe Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Romosozumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Romosozumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Romosozumab Market Size by Type
  2. 10.1.1 China Romosozumab Revenue by Type (2021-2032)
  3. 10.1.2 China Romosozumab Sales by Type (2021-2032)
  4. 10.1.3 China Romosozumab Price by Type (2021-2032)
  5. 10.2 China Romosozumab Market Size by Application
  6. 10.2.1 China Romosozumab Revenue by Application (2021-2032)
  7. 10.2.2 China Romosozumab Sales by Application (2021-2032)
  8. 10.2.3 China Romosozumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Romosozumab Market Size by Type
  2. 11.1.1 Asia Romosozumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Romosozumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Romosozumab Price by Type (2021-2032)
  5. 11.2 Asia Romosozumab Market Size by Application
  6. 11.2.1 Asia Romosozumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Romosozumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Romosozumab Price by Application (2021-2032)
  9. 11.3 Asia Romosozumab Market Size by Country
  10. 11.3.1 Asia Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Romosozumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Romosozumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Romosozumab Market Size by Type
  2. 12.1.1 SAMEA Romosozumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Romosozumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Romosozumab Price by Type (2021-2032)
  5. 12.2 SAMEA Romosozumab Market Size by Application
  6. 12.2.1 SAMEA Romosozumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Romosozumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Romosozumab Price by Application (2021-2032)
  9. 12.3 SAMEA Romosozumab Market Size by Country
  10. 12.3.1 SAMEA Romosozumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Romosozumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Romosozumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Romosozumab Value Chain Analysis
  2. 13.1.1 Romosozumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Romosozumab Production Mode & Process
  6. 13.2 Romosozumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Romosozumab Distributors
  9. 13.2.3 Romosozumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst